Bristol-Myers Squibb Company

Location

New Jersey

Founded

1887-04-10

Risk Signals

10470 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Bristol-Myers Squibb Company

Live alerts from global media, monitored by Business Radar

3 Stocks Seeing Insider Buys: CNC, PFE, BMY

2024-11-12 (yahoo.com)

3 Stocks Seeing Insider Buys: CNC, PFE, BMY

Investors can see insider buys as an overall net positive concerning the longer-term outlook for a stock.

Read more
Bristol-Myers Squibb (NYSE:BMY) Sets New 52-Week High on Insider Buying Activity

2024-11-06 (marketbeat.com)

Bristol-Myers Squibb (NYSE:BMY) Sets New 52-Week High on Insider Buying Activity

Bristol-Myers Squibb (NYSE:BMY) Reaches New 52-Week High After Insider Buying Activity

Read more
Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order

2022-11-24 (medicaldialogues.in)

Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order

New Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous manner' regarding implementation of its orders...

Read more
Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider

2022-06-27 (bioprocessintl.com)

Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider

J&J and BMS have spoken of plans to increase supply of lentivirus as they continue to roll out their respective CAR-T therapies.

Read more
Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider

2022-06-27 (bioprocessintl.com)

Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider

J&J and BMS have spoken of plans to increase supply of lentivirus as they continue to roll out their respective CAR-T therapies.

Read more
Bristol-myers Squibb (BMY) Trading Report

2022-01-31 (marketwatch.com)

Bristol-myers Squibb (BMY) Trading Report

Jan 31, 2022 (Stock Traders Daily via COMTEX) -- Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to...

Read more
FILING DEADLINE--Kuznicki Law PLLC Announces Class... | INN

2021-11-16 (investingnews.com)

FILING DEADLINE--Kuznicki Law PLLC Announces Class... | INN

The securities litigation law firm of Kuznicki Law PLLC issues th

Read more
As prosecutor, Christie struck unusual deals

2019-12-18 (inquirer.com)

As prosecutor, Christie struck unusual deals

As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at

Read more
As prosecutor, Christie struck unusual deals

2019-12-18 (inquirer.com)

As prosecutor, Christie struck unusual deals

As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at

Read more
As prosecutor, Christie struck unusual deals

2019-12-18 (inquirer.com)

As prosecutor, Christie struck unusual deals

As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at

Read more
Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges

2019-12-17 (inquirer.com)

Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges

Former Bristol-Myers Squibb executive Robert Ramnarine of East Brunswick, N.J., pleaded guilty Monday in federal court in Trenton to charges that he got rich by using advance knowledge of the company's pending acquisition on Amylin in 2012.

Read more
Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges

2019-12-17 (inquirer.com)

Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges

Former Bristol-Myers Squibb executive Robert Ramnarine of East Brunswick, N.J., pleaded guilty Monday in federal court in Trenton to charges that he got rich by using advance knowledge of the company's pending acquisition on Amylin in 2012.

Read more

Never miss a headline about Bristol-Myers Squibb Company

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages